Ready to play
Ready to play
Researchers at Mount Sinai Hospital in the United States have discovered that an artificial intelligence model known as "IICM+" can predict the risk of early-stage breast cancer recurrence more accurately than common genetic tests. The model utilizes images and other data to estimate the likelihood of the disease returning after more than five years from diagnosis, thereby enhancing early diagnosis prospects and enabling more precise treatment guidance.
Notice: This Is an AI-Generated Summary
Comments (0)